Drug Type CAR-T |
Synonyms- |
Target |
Mechanism CD19 modulators(B-lymphocyte antigen CD19 modulators), CD22 modulators(CD22 modulators), Immunologic cytotoxicity + [1] |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia | Phase 2 | CN | 20 Apr 2024 | |
Pre B-cell acute lymphoblastic leukemia | Phase 2 | CN | 20 Apr 2024 |